Difference between revisions of "Journal Club"
| Line 6: | Line 6: | ||
!scope="col" style="padding:.4em" | Presenter | !scope="col" style="padding:.4em" | Presenter | ||
!scope="col" style="padding:.4em" | Paper title | !scope="col" style="padding:.4em" | Paper title | ||
| + | |- | ||
| + | |style="padding:.4em;" rowspan=2|2017/05/17 | ||
| + | |style="padding:.4em;"|17-29 | ||
| + | |style="padding:.4em;"| | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.10.020 Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.] | ||
| + | |- | ||
| + | |style="padding:.4em;"|17-28 | ||
| + | |style="padding:.4em;"| | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.10.018 Host and Environmental Factors Influencing Individual Human Cytokine Responses.] | ||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/04/26 | |style="padding:.4em;" rowspan=2|2017/04/26 | ||
| + | |style="padding:.4em;"|17-27 | ||
| + | |style="padding:.4em;"| | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.10.017 A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans.] | ||
| + | |- | ||
| + | |style="padding:.4em;"|17-26 | ||
| + | |style="padding:.4em;"| | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.11.039 Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq.] | ||
| + | |- | ||
| + | |style="padding:.4em;"|17-25 | ||
| + | |style="padding:.4em;"| | ||
| + | |style="padding:.4em;text-align:left"| | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1016%2Fj.cell.2016.11.048 A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.] | ||
| + | |- | ||
| + | |style="padding:.4em;" rowspan=2|2017/04/19 | ||
|style="padding:.4em;"|17-24 | |style="padding:.4em;"|17-24 | ||
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
| Line 18: | Line 45: | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038%2Fnbt.3718 Genome-wide mapping of mutations at single-nucleotide resolution for protein, metabolic and genome engineering.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038%2Fnbt.3718 Genome-wide mapping of mutations at single-nucleotide resolution for protein, metabolic and genome engineering.] | ||
|- | |- | ||
| − | |style="padding:.4em;" rowspan=2|2017/04/ | + | |style="padding:.4em;" rowspan=2|2017/04/12 |
|style="padding:.4em;"|17-22 | |style="padding:.4em;"|17-22 | ||
|style="padding:.4em;"| | |style="padding:.4em;"| | ||
| Line 28: | Line 55: | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1126%2Fscience.1254257 Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.] | [https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1126%2Fscience.1254257 Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|style="padding:.4em;" rowspan=2|2017/04/05 | |style="padding:.4em;" rowspan=2|2017/04/05 | ||
Revision as of 17:43, 13 February 2017
2012
2011
2010